biopharma-reporter6d
An overview of the biosimilars space
Finally, the number of opportunities in the biosimilars space is very high — there are more than 300 biologics in the market, ...
biopharma-reporter6d
FDA approves first-ever gene therapy to be directly administered to the brain
PTC Therapeutics has received FDA approval for a gene therapy to treat AADC deficiency, a rare genetic disorder that impairs ...
biopharma-reporter5d
Samsung Biologics and European pharma company enter major manufacturing deal
The global contract development and manufacturing organization ​ (CDMO), Samsung Biologics, announced this week that it has ...
biopharma-reporter6d
Serious adverse event causes problems for Neurogene’s Rett gene therapy
A serious adverse event in the New York biotech’s phase 1/2 trial of its Rett syndrome gene therapy puts a question mark over ...
biopharma-reporter6d
Innovative COA tools to reduce steroid toxicity in autoimmune care
The STOX Suite is a digital platform that standardizes the measurement of steroid-toxicity, enabling researchers and ...
biopharma-reporter5d
Helen Harrington’s journey: Patience, passion, and problem-solving
From developing treatments for Ebola to mastering karate with her daughters, Dr. Helen Harrington’s journey is one of ...
biopharma-reporter5d
Phase 3 win for Protagonist Therapeutics with oral plaque psoriasis drug
The promising trial results put icotrokinra on track to fulfill its potential as a best in class oral therapeutic for the chronic skin condition. The phase 3 ICONIC-LEAD study showed that icotrokinra, ...